GoodRx Stock Slides After Amazon Debuts Prescription Delivery

Rachel Uranga

Rachel Uranga is dot.LA's Managing Editor, News. She is a former Mexico-based market correspondent at Reuters and has worked for several Southern California news outlets, including the Los Angeles Business Journal and the Los Angeles Daily News. She has covered everything from IPOs to immigration. Uranga is a graduate of the Columbia School of Journalism and California State University Northridge. A Los Angeles native, she lives with her husband, son and their felines.

GoodRx Stock Slides After Amazon Debuts Prescription Delivery

GoodRx shares plummeted more than 20% Tuesday after Amazon announced its plunging into the pharmacy space with delivery prescriptions.

Amazon, which acquired online pharmacy PillPack in 2018, is attempting to go head to head with big-box retailers with service currently in 45 states.

The news rippled through the industry sending shares of CVS, Walgreens and Rite Aid tumbling but it especially slammed discount prescription app GoodRx, which depends on all those for its business.

Amazon Pharmacy accepts insurance but also is appealing to those without insurance, the same market that GoodRx caters to with its comparison drug pricing for different pharmacies.

The Seattle retail giant will offer Prime members without insurance discounts of up to 80% off generic drugs and 40% off brand name medications at its pharmacy and through 50,000 additional pharmacies nationally. And it promises members free two-day delivery. It will not deliver opioids.

GoodRx, which made its Wall Street debut this year, acknowledged in Securities and Exchange Commission filings that one of the larger threats to their business is a shift toward mail order drugs.

Earlier this month, GoodRx forecast 40% year-over-year revenue growth next year.

https://twitter.com/racheluranga
rachel@dot.la

Subscribe to our newsletter to catch every headline.

Cadence

How Real-Time Data Is Helping Physicians Track Their Patients, One Heartbeat at a Time

S.C. Stuart
S.C. Stuart is a foreign correspondent (ELLE China, Esquire Latin America), Contributing Writer at Ziff Davis PCMag, and consults as a futurist for Hollywood Studios. Previously, S.C. was the head of digital at Hearst Magazines International while serving as a Non-Executive Director, UK Trade & Investment (US) and Digital Advisor at The Smithsonian.
How Real-Time Data Is Helping Physicians Track Their Patients, One Heartbeat at a Time

Are you a human node on a health-based digital network?

According to research from Insider Intelligence, the U.S. smart wearable user market is poised to grow 25.5% in 2023. Which is to say, there are an increasing number of Angelenos walking around this city whose vital signs can be tracked day and night via their doctor's digital device. If you've signed up to a health-based portal via a workplace insurance scheme, or through a primary care provider's portal which utilizes Google Fit, you’re one of them.

Do you know your baseline health status and resting heartbeat? Can you track your pulse, and take your own blood pressure? Have you received genetic counseling based on the sequencing of your genome? Do you avoid dairy because it bloats, or because you know you possess the variant that indicates lactose intolerance?

Read moreShow less

Who Will Win LA's E-scooter Wars?

Maylin Tu
Maylin Tu is a freelance writer who lives in L.A. She writes about scooters, bikes and micro-mobility. Find her hovering by the cheese at your next local tech mixer.
Who Will Win LA's E-scooter Wars?
Evan Xie

Los Angeles — it’s not just beautiful weather, traffic and the Hollywood Walk of Fame — it’s also the largest shared micromobility market in the U.S. with six operators permitted to deploy up to 6,000 vehicles each.

And despite the open market policy, the competition shows no signs of slowing down.

Read moreShow less
RELATEDEDITOR'S PICKS
LA TECH JOBS
interchangeLA
Trending